Johnson & Johnson

JNJ-N

NYSE:JNJ

143.26
5.78 (4.20%)
Johnson & Johnson is an American multinational medical devices, pharmaceutical and consumer packaged goods manufacturing company founded in 1886.
More at Wikipedia

Analysis and Opinions about JNJ-N

Signal
Opinion
Expert
PAST TOP PICK
PAST TOP PICK
May 11, 2006
(A Top Pick Feb 9/06. No change.) This was his insurance in case things got a little rocky. Still likes.
Show full opinionHide full opinion
(A Top Pick Feb 9/06. No change.) This was his insurance in case things got a little rocky. Still likes.
BUY
BUY
March 30, 2006
Has suffered from a lot that is happening in the pharmaceutical area. Pharmaceutical stocks are some of the cheapest around. A good solid company and if you have a long-term approach, it's a good buy here.
Show full opinionHide full opinion
Has suffered from a lot that is happening in the pharmaceutical area. Pharmaceutical stocks are some of the cheapest around. A good solid company and if you have a long-term approach, it's a good buy here.
WATCH
WATCH
February 28, 2006
They like it because of their cardiac care, health and beauty products. They are not crazy about the patented medicine part of the company. It is nicely positioned in the market. It has had a bit of a rocky road downhill. They are reviewing it and may be getting out.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 28, 2006
They like it because of their cardiac care, health and beauty products. They are not crazy about the patented medicine part of the company. It is nicely positioned in the market. It has had a bit of a rocky road downhill. They are reviewing it and may be getting out.
DON'T BUY
DON'T BUY
February 28, 2006
Think the worst is over for the pharmaceutical industry. J & J is also into medical devices, and consumer products. The stock had been outperforming other pharmaceutical but now the others are outperforming J & J. He likes Phiser, and Teva Pharmaceutical.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 28, 2006
Think the worst is over for the pharmaceutical industry. J & J is also into medical devices, and consumer products. The stock had been outperforming other pharmaceutical but now the others are outperforming J & J. He likes Phiser, and Teva Pharmaceutical.
SELL
SELL
February 14, 2006
Has been mispriced. Due for a correction
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 14, 2006
Has been mispriced. Due for a correction
TOP PICK
TOP PICK
February 9, 2006
Has had a rough go since last March. Trading at around 16 X earnings. Have $14 billion in cash and generate $1 billion in cash each month. Thinks it has bottomed out.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 9, 2006
Has had a rough go since last March. Trading at around 16 X earnings. Have $14 billion in cash and generate $1 billion in cash each month. Thinks it has bottomed out.
WAIT
WAIT
February 7, 2006
He has a model price of $55.63 which is a negative differential of about 2%. It has to finish its downward run. He would wait until about $48.75/49 before buying.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 7, 2006
He has a model price of $55.63 which is a negative differential of about 2%. It has to finish its downward run. He would wait until about $48.75/49 before buying.
TOP PICK
TOP PICK
February 1, 2006
They were fighting with Boston Scientific (BSX-N) for an acquisition and lost. However, Boston Scientific has acquired a company larger than itself and will have to take on enormous debt and historically, these have turned out to be crippling deals.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
February 1, 2006
They were fighting with Boston Scientific (BSX-N) for an acquisition and lost. However, Boston Scientific has acquired a company larger than itself and will have to take on enormous debt and historically, these have turned out to be crippling deals.
BUY
BUY
January 31, 2006
Stock is down 9% over last year. All the big US pharmas are off a lot and this was the last one to fall. It has the best product range and does a very good job. He continues to like it.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
January 31, 2006
Stock is down 9% over last year. All the big US pharmas are off a lot and this was the last one to fall. It has the best product range and does a very good job. He continues to like it.
DON'T BUY
DON'T BUY
January 4, 2006
Seening a little more strength on the pharmaceutical side. He would still prefer to go to the generics.
Show full opinionHide full opinion
Seening a little more strength on the pharmaceutical side. He would still prefer to go to the generics.
BUY
BUY
November 8, 2005
Finds the valuation a little bit high relative to the growth rate. A strong brand name. You can buy this and put it away for a number of years. Very low risk.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
November 8, 2005
Finds the valuation a little bit high relative to the growth rate. A strong brand name. You can buy this and put it away for a number of years. Very low risk.
WAIT
WAIT
August 31, 2005
Sold off when it broke a technical signal in the early spring. Starting to look interesting at this price. Has a lot of free cash flow. It's only 50% pharmaceutical with the rest being consumer products. All the big pharmas are under pressure because of some hearings in the next few weeks.
Show full opinionHide full opinion
Sold off when it broke a technical signal in the early spring. Starting to look interesting at this price. Has a lot of free cash flow. It's only 50% pharmaceutical with the rest being consumer products. All the big pharmas are under pressure because of some hearings in the next few weeks.
BUY
BUY
June 22, 2005
This has not been a great environment in the last few years for drug stocks, but J&J has been an exception. A diversified medical company with all kinds of businesses. Has been the best performing drug stock and thinks it will continue to be.
Show full opinionHide full opinion
This has not been a great environment in the last few years for drug stocks, but J&J has been an exception. A diversified medical company with all kinds of businesses. Has been the best performing drug stock and thinks it will continue to be.
VAGUE
VAGUE
December 16, 2004
The only drug company they own and it is for the medical devices and for the consumer products rather than the pharmaceuticals.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
December 16, 2004
The only drug company they own and it is for the medical devices and for the consumer products rather than the pharmaceuticals.
VAGUE
VAGUE
November 10, 2004
Has the best fundamentals of all the drug stocks. Drug sector has come under a number of significant pressures.
Show full opinionHide full opinion
Johnson & Johnson (JNJ-N)
November 10, 2004
Has the best fundamentals of all the drug stocks. Drug sector has come under a number of significant pressures.
Showing 376 to 390 of 444 entries